Gabapentin will not cure the opioid crisis. JAMA Internal Medicine The editors argued in response to a recent study of overlap between gabapentin and opioid prescriptions.
The Institute for Clinical and Economic Review (ICER), the drug pricing watchdog, has revised its report on the comparison of efficacy and value of multiple sclerosis (MS) drugs, highlighting the anti-CD20 approved for relapse. To include the drug ublituximab (Briumvi). MS last week.
As the FDA’s Jan. 6 decision approaches, ICER said the price of lecanemab, an investigational drug for early Alzheimer’s disease, should be kept below $20,600 annually.
Which new Alzheimer’s treatment are researchers most optimistic about? Four experts from the University of California, San Francisco have their say. (UCSF News)
In cases like Miami Dolphins quarterback Tua Tagovailoa, the NFL may have missed the symptoms and discovered the concussion too late.new york times)
See how spines form in an artificial human embryo. (Nature)
A case-control study of Medicare beneficiaries suggests that older adults with unrecognized Parkinson’s disease may exhibit motor symptoms up to 3 years before diagnosis. (Department of Neurology, JAMA)
Some centenarians appeared to be resilient to the highest levels of Alzheimer’s neuropathology.Alzheimer’s disease and dementia)
MRI biomarkers helped distinguish between migraine and cluster headache patients. (Neurological Annals)
What will neurology education look like in 2035?neurology)
